Cooperative activation of D1-like and D2-like dopamine receptors in the nucleus accumbens shell is required for the reinstatement of cocaine-seeking behavior in the rat

Neuroscience

Volumn 142, Issue 2, 2006, Pages 451-461

  Schmidt, H D ^a   Pierce, R C ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

addiction; quinpirole; relapse; SCH 23390; SKF 81297; sulpiride

Indexed keywords

6 CHLORO 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; COCAINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; QUINPIROLE; SODIUM CHLORIDE; SULPIRIDE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CONTROLLED STUDY; DOPAMINERGIC ACTIVITY; DOPAMINERGIC SYSTEM; MALE; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REINFORCEMENT;

ANIMALS; BEHAVIOR, ANIMAL; COCAINE; COCAINE-RELATED DISORDERS; DOPAMINE AGONISTS; DOPAMINE ANTAGONISTS; DOPAMINE UPTAKE INHIBITORS; DRUG INTERACTIONS; MALE; NUCLEUS ACCUMBENS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; REINFORCEMENT (PSYCHOLOGY); REINFORCEMENT SCHEDULE;

EID: 33748944455     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2006.06.004     Document Type: Article

References (68)

1. Aizman O., Brismar H., Uhlen P., Zettergren E., Levey A.I., Forssberg H., Greengard P., and Aperia A. Anatomical and physiological evidence for D1 and D2 dopamine receptor colocalization in neostriatal neurons. Nat Neurosci 3 (2000) 226-230
2. Alam A.M., and Starr M.S. Effects of dopamine D3 receptor agonists on pilocarpine-induced limbic seizures in the rat. Neuroscience 60 (1994) 1039-1047
3. Alleweireldt A.T., Weber S.M., Kirschner K.F., Bullock B.L., and Neisewander J.L. Blockade or stimulation of D1 dopamine receptors attenuates cue reinstatement of extinguished cocaine-seeking behavior in rats. Psychopharmacology (Berl) 159 (2002) 284-293
4. Andersen P.H. Comparison of the pharmacological characteristics of [3H]raclopride and [3H]SCH 23390 binding to dopamine receptors in vivo in mouse brain. Eur J Pharmacol 146 (1988) 113-120
5. Andersen P.H., and Jansen J.A. Dopamine receptor agonists: selectivity and dopamine D1 receptor efficacy. Eur J Pharmacol 188 (1990) 335-347
6. Anderson S.M., Bari A.A., and Pierce R.C. Administration of the D1-like dopamine receptor antagonist SCH-23390 into the medial nucleus accumbens shell attenuates cocaine priming-induced reinstatement of drug-seeking behavior in rats. Psychopharmacology (Berl) 168 (2003) 132-138
7. Anderson S.M., Schmidt H.D., and Pierce R.C. Administration of the D2 dopamine receptor antagonist sulpiride into the shell, but not the core, of the nucleus accumbens attenuates cocaine priming-induced reinstatement of drug seeking. Neuropsychopharmacology 31 (2006) 1452-1461
8. Bachtell R.K., Whisler K., Karanian D., and Self D.W. Effects of intranucleus accumbens shell administration of dopamine agonists and antagonists on cocaine-taking and cocaine-seeking behaviors in the rat. Psychopharmacology (Berl) 183 (2005) 41-53
9. Baker D.A., Khroyan T.V., O'Dell L.E., Fuchs R.A., and Neisewander J.L. Differential effects of intra-accumbens sulpiride on cocaine-induced locomotion and conditioned place preference. J Pharmacol Exp Ther 279 (1996) 392-401
10. Barnett A., Ahn H.S., Billard W., Gold E.H., Kohli J.D., Glock D., and Goldberg L.I. Relative activities of SCH 23390 and its analogs in three tests for D1/DA1 dopamine receptor antagonism. Eur J Pharmacol 128 (1986) 249-253
11. Beyer C.E., and Steketee J.D. Intra-medial prefrontal cortex injection of quinpirole, but not SKF 38393, blocks the acute motor-stimulant response to cocaine in the rat. Psychopharmacology (Berl) 151 (2000) 211-218
12. Beyer C.E., and Steketee J.D. Cocaine sensitization: modulation by dopamine D2 receptors. Cereb Cortex 12 (2002) 526-535
13. Bossert J.M., Ghitza U.E., Lu L., Epstein D.H., and Shaham Y. Neurobiology of relapse to heroin and cocaine seeking: an update and clinical implications. Eur J Pharmacol 526 (2005) 36-50
14. Brami-Cherrier K., Valjent E., Garcia M., Pages C., Hipskind R.A., and Caboche J. Dopamine induces a PI3-kinase-independent activation of Akt in striatal neurons: a new route to cAMP response element-binding protein phosphorylation. J Neurosci 22 (2002) 8911-8921
15. Caine S.B., Heinrichs S.C., Coffin V.L., and Koob G.F. Effects of the dopamine D-1 antagonist SCH 23390 microinjected into the accumbens, amygdala or striatum on cocaine self-administration in the rat. Brain Res 692 (1995) 47-56
16. Clark D., and White F.J. D1 dopamine receptor: the search for a function: a critical evaluation of the D1/D2 dopamine receptor classification and its functional implications. Synapse 1 (1987) 347-388
17. Cole R.L., Konradi C., Douglass J., and Hyman S.E. Neuronal adaptation to amphetamine and dopamine: molecular mechanisms of prodynorphin gene regulation in rat striatum. Neuron 14 (1995) 813-823
18. Cools A.R., Lubbers L., van Oosten R.V., and Andringa G. SKF 83959 is an antagonist of dopamine D1-like receptors in the prefrontal cortex and nucleus accumbens: a key to its antiparkinsonian effect in animals?. Neuropharmacology 42 (2002) 237-245
19. Cornish J.L., and Kalivas P.W. Glutamate transmission in the nucleus accumbens mediates relapse in cocaine addiction. J Neurosci 20 (2000) RC89
20. De Vries T.J., Schoffelmeer A.N., Binnekade R., Raaso H., and Vanderschuren L.J. Relapse to cocaine- and heroin-seeking behavior mediated by dopamine D2 receptors is time-dependent and associated with behavioral sensitization. Neuropsychopharmacology 26 (2002) 18-26
21. De Vries T.J., Schoffelmeer A.N., Binnekade R., and Vanderschuren L.J. Dopaminergic mechanisms mediating the incentive to seek cocaine and heroin following long-term withdrawal of IV drug self-administration. Psychopharmacology (Berl) 143 (1999) 254-260
22. Doll M.K., Nichols D.E., Kilts J.D., Prioleau C., Lawler C.P., Lewis M.M., and Mailman R.B. Synthesis and dopaminergic properties of benzo-fused analogues of quinpirole and quinelorane. J Med Chem 42 (1999) 935-940
23. Essman W.D., McGonigle P., and Lucki I. Anatomical differentiation within the nucleus accumbens of the locomotor stimulatory actions of selective dopamine agonists and d-amphetamine. Psychopharmacology (Berl) 112 (1993) 233-241
24. Fuchs R.A., Tran-Nguyen L.T., Weber S.M., Khroyan T.V., and Neisewander J.L. Effects of 7-OH-DPAT on cocaine-seeking behavior and on re-establishment of cocaine self-administration. Pharmacol Biochem Behav 72 (2002) 623-632
25. Gerfen C.R., Keefe K.A., and Gauda E.B. D1 and D2 dopamine receptor function in the striatum: coactivation of D1- and D2-dopamine receptors on separate populations of neurons results in potentiated immediate early gene response in D1-containing neurons. J Neurosci 15 (1995) 8167-8176
26. Gong W., Neill D.B., Lynn M., and Justice Jr. J.B. Dopamine D1/D2 agonists injected into nucleus accumbens and ventral pallidum differentially affect locomotor activity depending on site. Neuroscience 93 (1999) 1349-1358
27. Hopf F.W., Cascini M.G., Gordon A.S., Diamond I., and Bonci A. Cooperative activation of dopamine D1 and D2 receptors increases spike firing of nucleus accumbens neurons via G-protein betagamma subunits. J Neurosci 23 (2003) 5079-5087
28. Hopf F.W., Mailliard W.S., Gonzalez G.F., Diamond I., and Bonci A. Atypical protein kinase C is a novel mediator of dopamine-enhanced firing in nucleus accumbens neurons. J Neurosci 25 (2005) 985-989
29. Ikemoto S., Glazier B.S., Murphy J.M., and McBride W.J. Role of dopamine D1 and D2 receptors in the nucleus accumbens in mediating reward. J Neurosci 17 (1997) 8580-8587
30. Katz J.L., and Higgins S.T. The validity of the reinstatement model of craving and relapse to drug use. Psychopharmacology (Berl) 168 (2003) 21-30
31. Keefe K.A., and Gerfen C.R. D1-D2 dopamine receptor synergy in striatum: effects of intrastriatal infusions of dopamine agonists and antagonists on immediate early gene expression. Neuroscience 66 (1995) 903-913
32. Khroyan T.V., Barrett-Larimore R.L., Rowlett J.K., and Spealman R.D. Dopamine D1- and D2-like receptor mechanisms in relapse to cocaine-seeking behavior: effects of selective antagonists and agonists. J Pharmacol Exp Ther 294 (2000) 680-687
33. Khroyan T.V., Platt D.M., Rowlett J.K., and Spealman R.D. Attenuation of relapse to cocaine seeking by dopamine D1 receptor agonists and antagonists in non-human primates. Psychopharmacology (Berl) 168 (2003) 124-131
34. Koch M., Schmid A., and Schnitzler H.U. Role of nucleus accumbens dopamine D1 and D2 receptors in instrumental and Pavlovian paradigms of conditioned reward. Psychopharmacology (Berl) 152 (2000) 67-73
35. Konradi C., Cole R.L., Heckers S., and Hyman S.E. Amphetamine regulates gene expression in rat striatum via transcription factor CREB. J Neurosci 14 (1994) 5623-5634
36. Koshikawa N., Kitamura M., Kobayashi M., and Cools A.R. Contralateral turning elicited by unilateral stimulation of dopamine D2 and D1 receptors in the nucleus accumbens of rats is due to stimulation of these receptors in the shell, but not the core, of this nucleus. Psychopharmacology (Berl) 126 (1996) 185-190
37. Lee S.P., So C.H., Rashid A.J., Varghese G., Cheng R., Lanca A.J., O'Dowd B.F., and George S.R. Dopamine D1 and D2 receptor co-activation generates a novel phospholipase C-mediated calcium signal. J Biol Chem 279 (2004) 35671-35678
38. Liu F.C., and Graybiel A.M. Spatiotemporal dynamics of CREB phosphorylation: transient versus sustained phosphorylation in the developing striatum. Neuron 17 (1996) 1133-1144
39. Lu X.Y., Ghasemzadeh M.B., and Kalivas P.W. Expression of D1 receptor, D2 receptor, substance P and enkephalin messenger RNAs in the neurons projecting from the nucleus accumbens. Neuroscience 82 (1998) 767-780
40. McGregor A., and Roberts D.C. Effect of medial prefrontal cortex injections of SCH 23390 on intravenous cocaine self-administration under both a fixed and progressive ratio schedule of reinforcement. Behav Brain Res 67 (1995) 75-80
41. Missale C., Nash S.R., Robinson S.W., Jaber M., and Caron M.G. Dopamine receptors: from structure to function. Physiol Rev 78 (1998) 189-225
42. Nowend K.L., Arizzi M., Carlson B.B., and Salamone J.D. D1 or D2 antagonism in nucleus accumbens core or dorsomedial shell suppresses lever pressing for food but leads to compensatory increases in chow consumption. Pharmacol Biochem Behav 69 (2001) 373-382
43. Park W.K., Bari A.A., Jey A.R., Anderson S.M., Spealman R.D., Rowlett J.K., and Pierce R.C. Cocaine administered into the medial prefrontal cortex reinstates cocaine-seeking behavior by increasing AMPA receptor-mediated glutamate transmission in the nucleus accumbens. J Neurosci 22 (2002) 2916-2925
44. Paxinos G., and Watson C. The rat brain in stereotaxic coordinates (1997), Academic Press, New York
45. Phillips G.D., Howes S.R., Whitelaw R.B., Robbins T.W., and Everitt B.J. Analysis of the effects of intra-accumbens SKF-38393 and LY-171555 upon the behavioural satiety sequence. Psychopharmacology (Berl) 117 (1995) 82-90
46. Phillips G.D., Robbins T.W., and Everitt B.J. Bilateral intra-accumbens self-administration of d-amphetamine: antagonism with intra-accumbens SCH-23390 and sulpiride. Psychopharmacology (Berl) 114 (1994) 477-485
47. Plaznik A., Stefanski R., and Kostowski W. Interaction between accumbens D1 and D2 receptors regulating rat locomotor activity. Psychopharmacology (Berl) 99 (1989) 558-562
48. Pollack A. Coactivation of D1 and D2 dopamine receptors: in marriage, a case of his, hers, and theirs. Sci STKE 2004 (2004) pe50
49. Ridray S., Griffon N., Mignon V., Souil E., Carboni S., Diaz J., Schwartz J.C., and Sokoloff P. Coexpression of dopamine D1 and D3 receptors in islands of Calleja and shell of nucleus accumbens of the rat: opposite and synergistic functional interactions. Eur J Neurosci 10 (1998) 1676-1686
50. Schenk S. Effects of GBR 12909, WIN 35,428 and indatraline on cocaine self-administration and cocaine seeking in rats. Psychopharmacology (Berl) 160 (2002) 263-270
51. Schenk S., and Gittings D. Effects of SCH 23390 and eticlopride on cocaine-seeking produced by cocaine and WIN 35,428 in rats. Psychopharmacology (Berl) 168 (2003) 118-123
52. Schmidt H.D., Anderson S.M., Famous K.R., Kumaresan V., and Pierce R.C. Anatomy and pharmacology of cocaine priming-induced reinstatement of drug seeking. Eur J Pharmacol 526 (2005) 65-76
53. Schmidt H.D., Anderson S.M., and Pierce R.C. Stimulation of D1-like or D2 dopamine receptors in the shell, but not the core, of the nucleus accumbens reinstates cocaine-seeking behavior in the rat. Eur J Neurosci 23 (2006) 219-228
54. Schmidt H.D., and Pierce R.C. Administration of D1-like or D2 dopamine receptors agonists into the nucleus accumbens shell reinstates cocaine-seeking behavior (2004) Proceedings of the Society for Neuroscience, San Diego, CA. Program number 237.16.2004. Abstract Viewer and Itinerary Planner.
55. Schwartz J.C., Diaz J., Bordet R., Griffon N., Perachon S., Pilon C., Ridray S., and Sokoloff P. Functional implications of multiple dopamine receptor subtypes: the D1/D3 receptor coexistence. Brain Res Brain Res Rev 26 (1998) 236-242
56. Self D.W., Barnhart W.J., Lehman D.A., and Nestler E.J. Opposite modulation of cocaine-seeking behavior by D1- and D2-like dopamine receptor agonists. Science 271 (1996) 1586-1589
57. Shalev U., Grimm J.W., and Shaham Y. Neurobiology of relapse to heroin and cocaine seeking: a review. Pharmacol Rev 54 (2002) 1-42
58. Sibley D.R., Monsma Jr. F.J., and Shen Y. Molecular neurobiology of dopaminergic receptors. Int Rev Neurobiol 35 (1993) 391-415
59. Sorg B.A., Li N., and Wu W.R. Dopamine D1 receptor activation in the medial prefrontal cortex prevents the expression of cocaine sensitization. J Pharmacol Exp Ther 297 (2001) 501-508
60. Spealman R.D., Barrett-Larimore R.L., Rowlett J.K., Platt D.M., and Khroyan T.V. Pharmacological and environmental determinants of relapse to cocaine-seeking behavior. Pharmacol Biochem Behav 64 (1999) 327-336
61. Svenningsson P., Fredholm B.B., Bloch B., and Le Moine C. Co-stimulation of D(1)/D(5) and D(2) dopamine receptors leads to an increase in c-fos messenger RNA in cholinergic interneurons and a redistribution of c-fos messenger RNA in striatal projection neurons. Neuroscience 98 (2000) 749-757
62. Tang L., Todd R.D., Heller A., and O'Malley K.L. Pharmacological and functional characterization of D2, D3 and D4 dopamine receptors in fibroblast and dopaminergic cell lines. J Pharmacol Exp Ther 268 (1994) 495-502
63. Vallone D., Picetti R., and Borrelli E. Structure and function of dopamine receptors. Neurosci Biobehav Rev 24 (2000) 125-132
64. Vincent S.R., Sebben M., Dumuis A., and Bockaert J. Neurotransmitter regulation of MAP kinase signaling in striatal neurons in primary culture. Synapse 29 (1998) 29-36
65. Vorel S.R., Ashby Jr. C.R., Paul M., Liu X., Hayes R., Hagan J.J., Middlemiss D.N., Stemp G., and Gardner E.L. Dopamine D3 receptor antagonism inhibits cocaine-seeking and cocaine-enhanced brain reward in rats. J Neurosci 22 (2002) 9595-9603
66. White N.M., Packard M.G., and Hiroi N. Place conditioning with dopamine D1 and D2 agonists injected peripherally or into nucleus accumbens. Psychopharmacology (Berl) 103 (1991) 271-276
67. Wise R.A., Murray A., and Bozarth M.A. Bromocriptine self-administration and bromocriptine-reinstatement of cocaine-trained and heroin-trained lever pressing in rats. Psychopharmacology (Berl) 100 (1990) 355-360
68. Yan Z., Feng J., Fienberg A.A., and Greengard P. D(2) dopamine receptors induce mitogen-activated protein kinase and cAMP response element-binding protein phosphorylation in neurons. Proc Natl Acad Sci U S A 96 (1999) 11607-11612